With about 20% of young adults infected with one of the herpes simplex viruses (HSV) in 2024, the World Health Organization (WHO) recently raised awareness of the related costs and vaccine candidate landscape.
On December 11, 2024, the WHO revealed that the Global Health Sector Strategy on HIV, viral hepatitis, and sexually transmitted infections for 2022-2030 highlighted the cost of genital herpes infections. The WHO reaffirmed that it is also working to advance research and develop new prevention tools, such as vaccines.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
